Search

everythinglearnresearchcommunity

for

Search:↓

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Applying estradiol to skin causes local changes but not cancer.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Valette® is an effective birth control pill that also reduces greasy hair and skin.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

A new method accurately measures DHEAS in blood, improving on current tests.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

The combination therapy effectively treats infertility in PCOS without major side effects.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

The treatment slightly increased hair growth and was safe for most women.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.